[Tactics for the correction of intestinal microbiocenotic disorders in the combination therapy of patients with chronic liver diseases].

Aim: To evaluate the efficacy of the symbiotic Linex used in the combination therapy of liver cirrhosis (LC).

Subjects And Methods: Seventy-four patients with LC, including 44 who received additionally the symbiotic Linex and 30 who had conventional therapy, were examined. All the patients underwent clinical and biochemical blood tests, abdominal ultrasonography, fecal test for bacteria, gas chromatography-mass spectrometry of the blood composition of microbial markers, number connecting test, and quality-of-life assessment (SF-36).